Receipt of Weight Management Services Among Patients With OSA and Obesity

Aristotle G Leonhard1, Jennifer McDowell1, Katherine D Hoerster1

  • 1Division of Pulmonary, Critical Care, and Sleep Medicine (A. G. L., S. H., F. P., J. M. C., K. I. D., L. C. F., D. H. A., and L. M. D.) and the Department of Psychiatry and Behavioral Sciences (K. D. H.), The University of Washington, Seattle, WA; Division of Pulmonary, Critical Care, and Sleep Medicine (L. C. F., D. H. A., and L. M. D.), Seattle Division, Health Services Research and Development (J. M., K. D. H., L. C. F., D. H. A., and L. M. D.), and the Seattle Division, Mental Health Service (K. D. H.), VA Puget Sound Healthcare System, Seattle, WA; Center of Care and Payment Innovation (D. H. A.), Office of Healthcare Innovation and Learning, Department of Veterans Affairs, Washington, DC; Department of Biostatistics & Informatics (K. J.), Colorado School of Public Health, Aurora, CO; The Veterans Affairs Eastern Colorado Health Care System (M. G.), Aurora, CO; Division of Academic Internal Medicine and Geriatrics (J. M.), Department of Medicine, The University of Illinois Chicago, Chicago, IL; and the Division of Respiratory Medicine (K. I. D.), The University of British Columbia, Vancouver, BC, Canada.

CHEST Pulmonary
|May 25, 2026
PubMed
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.